Enclomiphene is a non-steroidal estrogen-receptor antagonist promoting gonadotropin-dependent testosterone secretion.
Enclomiphene (Androxal), in development by Repros Therapeutics Inc, is a non-steroidal estrogen receptor antagonist that promotes gonadotropin-dependent testosterone secretion by the testes.
Enclomiphene, an estrogen receptor antagonist for the treatment of testosterone deficiency in men.
Evidence scope. Exact molecule; drug-development review; male secondary-hypogonadism context.